SEC Form 4 · accession 0001209191-18-044132
TRANSENTERIX INC. · TRXC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William N Starling Jr.
Director
Period of report
Jul 25, 2018
Accepted (ET)
Jul 27, 2018 · 9:00 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000876378
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 25, 2018 | M | 25,000 | $0.48 | A | 45,362 | D | |
| Common Stock | Jul 25, 2018 | M | 21,625 | $0.35 | A | 66,987 | D | |
| Common StockF1 | holding | — | — | — | 5,318,969 | I | See Footnote | |
| Common StockF2 | holding | — | — | — | 392,122 | I | See Footnote | |
| Common StockF3 | holding | — | — | — | 135,223 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF4 | $0.48 | Jul 25, 2018 | M | 25,000 | D | — | May 25, 2027 | Common Stock | 25,000 | 0 | D |
| Stock OptionF4 | $0.35 | Jul 25, 2018 | M | 21,625 | D | — | Apr 12, 2022 | Common Stock | 21,625 | 0 | D |
Explanation of responses
- F1Shares of Common Stock held by Synergy Life Science Partners, L.P. William N. Starling is a managing director of Synergy Life Science Partners, L.P.
- F2Shares of Common Stock held Synecor, L.L.C. William N. Starling is the chief executive officer of Synecor, L.L.C.
- F3Shares of Common Stock held by W. Starling and D. Starling, Trustees of the Starling Family Trust, UDT August 15, 1990.
- F4Previously vested.